A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/473 (2006.01) A61P 25/14 (2006.01)
Patent
CA 2615077
The invention provides 3,1 lb-cis-dihydrotetrabenazine for use in halting or slowing the progress of one or more symptoms of Huntington's disease in a patient, and more particularly a symptom selected from involuntary movements such as involuntary chorea, tremors and twitches, and degeneration in gait.
La présente invention concerne 3,1 lb-cis-dihydrotétrabenazine destiné à stopper ou ralentir la progression d'un ou de plusieurs symptômes de la maladie de Huntington chez un patient, et plus particulièrement un symptôme sélectionné parmi les mouvements involontaires tels que la chorée involontaires, les frayeurs et les secousses ainsi que la dégénération de la démarche.
Filloux Thierry
Tridgett Robert
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Biovail Laboratories International (barbados) Srl
Cambridge Laboratories (ireland) Limited
LandOfFree
Use of 3,1ib-cis-dihydrotetrabenazine for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3,1ib-cis-dihydrotetrabenazine for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3,1ib-cis-dihydrotetrabenazine for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1994832